Bioengineers at the University of California San Diego have developed a powerful new technology that can map the entire network of RNA-protein interactions inside human cells—an achievement that could ...
CILA’s proprietary, gene-agnostic platform, CIL-Key™, is designed to enable the development of breakthrough inhaled RNA therapeutics and vaccines for pulmonary diseases — potentially unlocking new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback